Gut bacteria may signal Parkinson's risk years before symptoms emerge

Approximately 153,000 people in the UK currently have Parkinson's disease, with numbers expected to rise as the population ages.
Bacteria in the gut may reveal Parkinson's risk years before symptoms appear
UCL researchers found distinctive microbial patterns in people at genetic risk, even before disease onset.

Long before the first tremor announces itself, the body may already be whispering a warning — not in the brain, but in the gut. Researchers at University College London have found that the trillions of microbes inhabiting the digestive system carry a distinctive signature in people with Parkinson's disease, one that appears even in those who carry genetic risk but show no symptoms yet. For the roughly 153,000 people in the UK living with this degenerative condition — and the many more who may one day join them — the discovery suggests that the window for intervention might open far earlier than medicine has previously been able to see, and that something as ordinary as diet could hold unexpected protective power.

  • Scientists can now identify a microbial fingerprint in the gut that distinguishes Parkinson's patients from healthy people across more than 176 bacterial species — a difference so pronounced it spans over a quarter of the entire microbiome.
  • The most unsettling finding is that people who carry a high-risk genetic variant but feel perfectly well already show a gut bacterial pattern drifting toward the disease state, suggesting the biological clock starts ticking long before any symptom appears.
  • Even more troubling, these same warning patterns were detected in a portion of the general population with no known genetic risk, raising the possibility that silent vulnerability is more widespread than anyone anticipated.
  • Diet emerges as a potential lever: those with the high-risk microbial profile ate more processed foods and saturated fats and less fruit, vegetables, and fish — pointing toward lifestyle changes as a plausible early intervention.
  • Researchers caution that longer studies are needed before gut analysis can be used as a reliable predictive tool, but the trajectory is clear: microbiome screening and targeted dietary or pharmaceutical interventions may one day reshape how Parkinson's is caught and prevented.

A team at University College London has found that the bacteria living in the gut may signal Parkinson's disease years before the first tremor or slowness of movement appears. The discovery raises the possibility of catching the disease in its earliest, most treatable stage — and suggests that diet could play a meaningful role in prevention.

Parkinson's develops when brain cells stop producing dopamine, leading to tremors, stiffness, balance problems, and a cascade of other difficulties. Around 153,000 people in the UK live with the condition, and that number is expected to grow as the population ages.

Led by Professor Anthony Schapira, the UCL team examined the gut microbiomes of three groups: people already diagnosed with Parkinson's, people carrying a high-risk genetic variant called GBA1 but showing no symptoms, and healthy controls. More than a quarter of the gut microbiome differed between patients and healthy individuals, with 176 distinct bacterial species showing measurable changes. Crucially, the symptom-free genetic risk group displayed a microbial pattern that fell between the healthy and diseased groups — an early biological signature of a disease not yet arrived. The same patterns also appeared in a small portion of the general population with no known genetic risk.

Schapira described the gut microbiome as a potential early warning system, one that could identify danger long before the brain shows damage. The team also observed that people with the abnormal microbial signature tended to eat more processed foods and saturated fats, and less fruit, vegetables, and fish — a finding that hints at diet as a modifiable risk factor.

Longer studies are still needed to confirm whether these patterns can reliably predict who will develop the disease. But the prospect is significant: that a gut bacteria analysis could identify at-risk individuals years in advance, and that changes in what people eat — or targeted treatments — might prevent the disease from ever taking hold.

A team at University College London has discovered that the bacteria living in your gut may hold clues to whether you'll develop Parkinson's disease—potentially years before you feel the first tremor or notice your movements slowing. The finding opens a door to catching the disease before it takes hold, and suggests that what you eat might matter more than anyone realized.

Parkinson's is a degenerative neurological condition that develops when nerve cells in the brain stop producing dopamine, the chemical that orchestrates movement. As those cells die, patients experience tremors, stiffness, slowness, balance problems, and often depression, sleep disruption, and constipation. About 153,000 people in the UK live with the condition today, and that number will only climb as the population ages.

The UCL researchers, led by Professor Anthony Schapira, analyzed the microbiome—the trillions of bacteria and other organisms inhabiting the digestive system—of three groups: 271 people already diagnosed with Parkinson's, 43 people carrying a high-risk genetic variant called GBA1 (which can elevate disease risk up to 30-fold) but showing no symptoms, and 150 healthy controls. What they found was striking. More than a quarter of the gut microbiome differed between Parkinson's patients and healthy people—176 distinct microbial species showed measurable differences. Some bacteria were more abundant in patients; others less so.

What made the discovery particularly significant was what happened in the middle group. People carrying the genetic risk factor but not yet sick showed a gut bacterial pattern that sat between the healthy volunteers and the Parkinson's patients—an "in-between" signature. The same microbial changes that marked people with active disease were already present in people who hadn't yet developed symptoms. Even more intriguingly, researchers found these same patterns in a small slice of the general population with no known genetic risk, suggesting they too might face elevated danger.

Schapira emphasized the stakes. To develop treatments that actually work, scientists need "the means for very early detection." The gut microbiome, he suggested, could serve as an early warning system—a biological signal that disease might be coming long before the brain shows damage. "For the first time we identify bacteria in the gut of people with Parkinson's that can also be found in those with a genetic risk for the disease, but before they develop symptoms," he said.

The researchers also noticed something about diet. People with the abnormal microbiome signature tended to eat more processed foods and saturated fats, while consuming less fruit, vegetables, and fish. This hints at a potential intervention: changing what you eat might change your bacterial population, and changing your bacteria might reduce your risk. The team cautioned that longer studies are needed to confirm whether these microbial patterns can reliably predict who will actually get sick. But the possibility is tantalizing—that a simple analysis of gut bacteria could identify at-risk people years before symptoms emerge, and that dietary changes or targeted medications might prevent the disease from taking root at all.

Claire Bale, an associated director of research at Parkinson's UK, noted that the findings suggest microbiome changes happen in the earliest stages of the condition, and that the degree of change may track with how the disease progresses. Over the past decade, physical activity has shown promise in managing symptoms and potentially slowing the disease's course. Now, she said, the growing understanding of the gut microbiome offers similar hope that what people eat could benefit those living with Parkinson's—or perhaps prevent it altogether.

For the first time we identify bacteria in the gut of people with Parkinson's that can also be found in those with a genetic risk for the disease, but before they develop symptoms.
— Professor Anthony Schapira, UCL Queen Square Institute of Neurology
The findings indicate that changes in the microbiome may occur in the very early stages of the condition and that the extent of these changes may correlate with disease progression.
— Claire Bale, Parkinson's UK
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why does the gut matter for a disease of the brain?

Model

The connection is still being mapped, but we know the gut and brain communicate constantly through the nervous system and through chemical signals. Parkinson's involves loss of dopamine-producing cells, and the bacteria in your gut influence how your body produces and processes dopamine. If the bacterial ecosystem is out of balance, it may set the stage for neurological damage.

Inventor

So these researchers found that sick people have different bacteria than healthy people. Isn't that true for almost every disease?

Model

Fair point. But what's unusual here is that people who carry the genetic risk—who haven't gotten sick yet—already show the same bacterial pattern. That suggests the microbiome change isn't just a consequence of having Parkinson's. It might be part of what causes it, or at least a marker that the disease process has already begun.

Inventor

And diet changes the bacteria?

Model

Yes. People with the high-risk microbiome pattern ate more processed foods and saturated fats, less fruit and vegetables. That's not proof that diet caused the bacterial change, but it's a strong signal. If you can change bacteria through diet, you might be able to prevent the disease in people who are genetically vulnerable.

Inventor

How far away is this from actually helping patients?

Model

Still years away. They need long-term studies to confirm these bacteria actually predict who gets sick. But if they can, then a simple microbiome test could identify at-risk people decades before symptoms. That's the real prize—catching it before the brain damage happens.

Inventor

What happens to someone carrying the GBA1 gene?

Model

About 30 times more likely to develop Parkinson's than the general population. But not everyone with the gene gets sick. That's why this research matters—it might explain why some carriers develop the disease and others don't. The bacteria might be the missing piece.

Fale Conosco FAQ